Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:44 UTC |
---|
HMDB ID | HMDB0014775 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Astemizole |
---|
Description | Astemizole, also known as astemison or hismanal, belongs to the class of organic compounds known as benzimidazoles. These are organic compounds containing a benzene ring fused to an imidazole ring (five member ring containing a nitrogen atom, 4 carbon atoms, and two double bonds). Astemizole is a very strong basic compound (based on its pKa). In humans, astemizole is involved in astemizole h1-antihistamine action. Astemizole is a potentially toxic compound. A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-amino group at the 4-position. |
---|
Structure | COC1=CC=C(CCN2CCC(CC2)NC2=NC3=CC=CC=C3N2CC2=CC=C(F)C=C2)C=C1 InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31) |
---|
Synonyms | Value | Source |
---|
1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole | ChEBI | 1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole | ChEBI | Astemison | ChEBI | Astemizol | ChEBI | Astemizolum | ChEBI | Hismanal | Kegg | Alonga brand OF astemizole | HMDB | Astemizole alacan brand | HMDB | Astemizole byk brand | HMDB | Astemizole diba brand | HMDB | Astemizole esteve brand | HMDB | Astemizole senosiain brand | HMDB | Astemizole ratiopharm brand | HMDB | Esteve brand OF astemizole | HMDB | Fustery brand OF astemizole | HMDB | Histaminos | HMDB | ICN brand OF astemizole | HMDB | Rifedot | HMDB | Rimbol | HMDB | Senosiain brand OF astemizole | HMDB | Smaller brand OF astemizole | HMDB | Alonga, astemizol | HMDB | Astemina | HMDB | Astemizol alonga | HMDB | Astemizole icn brand | HMDB | Astemizole medinsa brand | HMDB | Astemizole merck brand | HMDB | Astemizole smaller brand | HMDB | Astemizole urbion brand | HMDB | Astemizole vita brand | HMDB | Astesen | HMDB | Hubermizol | HMDB | Laridal | HMDB | Lesvi brand OF astemizole | HMDB | Reig jofre brand OF astemizole | HMDB | Romadin | HMDB | Urbion brand OF astemizole | HMDB | Ratiopharm brand OF astemizole | HMDB | Ratiopharm, astemizol | HMDB | Astemizole alonga brand | HMDB | Astemizole elfar brand | HMDB | Astemizole fustery brand | HMDB | Astemizole janssen brand | HMDB | Astemizole lesvi brand | HMDB | Astemizole mcneil brand | HMDB | Astemizole septa brand | HMDB | Byk brand OF astemizole | HMDB | Diba brand OF astemizole | HMDB | Elfar brand OF astemizole | HMDB | Emdar | HMDB | Fustermizol | HMDB | McNeil brand OF astemizole | HMDB | Merck brand OF astemizole | HMDB | Simprox | HMDB | Urdrim | HMDB | Alacan brand OF astemizole | HMDB | Alermizol | HMDB | Astemizol ratiopharm | HMDB | Esmacen | HMDB | Janssen brand OF astemizole | HMDB | Medinsa brand OF astemizole | HMDB | Paralergin | HMDB | Retolen | HMDB | Septa brand OF astemizole | HMDB | Vita brand OF astemizole | HMDB |
|
---|
Chemical Formula | C28H31FN4O |
---|
Average Molecular Weight | 458.5703 |
---|
Monoisotopic Molecular Weight | 458.248189839 |
---|
IUPAC Name | 1-[(4-fluorophenyl)methyl]-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-1,3-benzodiazol-2-amine |
---|
Traditional Name | astemizole |
---|
CAS Registry Number | 68844-77-9 |
---|
SMILES | COC1=CC=C(CCN2CCC(CC2)NC2=NC3=CC=CC=C3N2CC2=CC=C(F)C=C2)C=C1 |
---|
InChI Identifier | InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31) |
---|
InChI Key | GXDALQBWZGODGZ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzimidazoles. These are organic compounds containing a benzene ring fused to an imidazole ring (five member ring containing a nitrogen atom, 4 carbon atoms, and two double bonds). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzimidazoles |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzimidazoles |
---|
Alternative Parents | |
---|
Substituents | - Benzimidazole
- Phenethylamine
- Anisole
- Phenoxy compound
- Phenol ether
- Methoxybenzene
- Alkyl aryl ether
- Fluorobenzene
- Halobenzene
- Aralkylamine
- Piperidine
- Benzenoid
- Aryl fluoride
- Aryl halide
- N-substituted imidazole
- Monocyclic benzene moiety
- Heteroaromatic compound
- Azole
- Imidazole
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Ether
- Hydrocarbon derivative
- Amine
- Organic oxygen compound
- Organic nitrogen compound
- Organohalogen compound
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 149.1 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0012 g/L | Not Available | LogP | 5.8 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Astemizole,1TMS,isomer #1 | COC1=CC=C(CCN2CCC(N(C3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)[Si](C)(C)C)CC2)C=C1 | 3820.7 | Semi standard non polar | 33892256 | Astemizole,1TMS,isomer #1 | COC1=CC=C(CCN2CCC(N(C3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)[Si](C)(C)C)CC2)C=C1 | 3431.0 | Standard non polar | 33892256 | Astemizole,1TMS,isomer #1 | COC1=CC=C(CCN2CCC(N(C3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)[Si](C)(C)C)CC2)C=C1 | 4880.0 | Standard polar | 33892256 | Astemizole,1TBDMS,isomer #1 | COC1=CC=C(CCN2CCC(N(C3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)[Si](C)(C)C(C)(C)C)CC2)C=C1 | 4020.1 | Semi standard non polar | 33892256 | Astemizole,1TBDMS,isomer #1 | COC1=CC=C(CCN2CCC(N(C3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)[Si](C)(C)C(C)(C)C)CC2)C=C1 | 3588.7 | Standard non polar | 33892256 | Astemizole,1TBDMS,isomer #1 | COC1=CC=C(CCN2CCC(N(C3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)[Si](C)(C)C(C)(C)C)CC2)C=C1 | 4887.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Astemizole GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-1922000000-2742ecd8a8c6af4db428 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Astemizole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 10V, Positive-QTOF | splash10-0a4i-0110900000-7c47b2813568251daf1e | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 20V, Positive-QTOF | splash10-052r-1947600000-b67040fd618da0f36a6a | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 40V, Positive-QTOF | splash10-0016-2940000000-e1a0cda3eae5d6bc1cf6 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 10V, Negative-QTOF | splash10-0a4i-0010900000-e80e4e306be153aeab7c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 20V, Negative-QTOF | splash10-0abc-0145900000-d00ee25e0101b4beb25a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 40V, Negative-QTOF | splash10-01qd-3893000000-dae89e0c7d17da3e1c78 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 10V, Positive-QTOF | splash10-0a4i-0000900000-416ae1ceda818e4c922c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 20V, Positive-QTOF | splash10-0a4i-0200900000-3d85252f27ae2ba0258e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 40V, Positive-QTOF | splash10-0570-1624900000-4ea28e09b60d7c3b3618 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 10V, Negative-QTOF | splash10-0a4i-0000900000-afe434091fa2787a5ed5 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 20V, Negative-QTOF | splash10-0a4i-0000900000-142d31f8c19fb007efb7 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Astemizole 40V, Negative-QTOF | splash10-0a59-0794800000-0f835aeecbc38bc493f2 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
General References | - Wang X, Hockerman GH, Green HW 3rd, Babbs CF, Mohammad SI, Gerrard D, Latour MA, London B, Hannon KM, Pond AL: Merg1a K+ channel induces skeletal muscle atrophy by activating the ubiquitin proteasome pathway. FASEB J. 2006 Jul;20(9):1531-3. Epub 2006 May 24. [PubMed:16723379 ]
- Chong CR, Chen X, Shi L, Liu JO, Sullivan DJ Jr: A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol. 2006 Aug;2(8):415-6. Epub 2006 Jul 2. [PubMed:16816845 ]
|
---|